These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 30333910)
1. RND1 regulates migration of human glioblastoma stem-like cells according to their anatomical localization and defines a prognostic signature in glioblastoma. Boyrie S; Delmas C; Lemarié A; Lubrano V; Dahan P; Malric L; Luis J; Gilhodes J; Tosolini M; Mouly L; Lehmann M; Toulas C; Cohen-Jonathan Moyal E; Monferran S Oncotarget; 2018 Sep; 9(73):33788-33803. PubMed ID: 30333910 [TBL] [Abstract][Full Text] [Related]
2. Stem cell signature in glioblastoma: therapeutic development for a moving target. Nakano I J Neurosurg; 2015 Feb; 122(2):324-30. PubMed ID: 25397368 [TBL] [Abstract][Full Text] [Related]
3. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells. Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969 [TBL] [Abstract][Full Text] [Related]
4. A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma. Chai R; Zhang K; Wang K; Li G; Huang R; Zhao Z; Liu Y; Chen J J Cancer Res Clin Oncol; 2018 Mar; 144(3):439-447. PubMed ID: 29299749 [TBL] [Abstract][Full Text] [Related]
5. Comparison of glioma stem cells to neural stem cells from the adult human brain identifies dysregulated Wnt- signaling and a fingerprint associated with clinical outcome. Sandberg CJ; Altschuler G; Jeong J; Strømme KK; Stangeland B; Murrell W; Grasmo-Wendler UH; Myklebost O; Helseth E; Vik-Mo EO; Hide W; Langmoen IA Exp Cell Res; 2013 Aug; 319(14):2230-43. PubMed ID: 23791939 [TBL] [Abstract][Full Text] [Related]
6. Differential proteomic analysis of human glioblastoma and neural stem cells reveals HDGF as a novel angiogenic secreted factor. Thirant C; Galan-Moya EM; Dubois LG; Pinte S; Chafey P; Broussard C; Varlet P; Devaux B; Soncin F; Gavard J; Junier MP; Chneiweiss H Stem Cells; 2012 May; 30(5):845-53. PubMed ID: 22331796 [TBL] [Abstract][Full Text] [Related]
7. The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells. Galavotti S; Bartesaghi S; Faccenda D; Shaked-Rabi M; Sanzone S; McEvoy A; Dinsdale D; Condorelli F; Brandner S; Campanella M; Grose R; Jones C; Salomoni P Oncogene; 2013 Feb; 32(6):699-712. PubMed ID: 22525272 [TBL] [Abstract][Full Text] [Related]
8. ADAM17 promotes U87 glioblastoma stem cell migration and invasion. Chen X; Chen L; Chen J; Hu W; Gao H; Xie B; Wang X; Yin Z; Li S; Wang X Brain Res; 2013 Nov; 1538():151-8. PubMed ID: 23470260 [TBL] [Abstract][Full Text] [Related]
9. REST represses miR-124 and miR-203 to regulate distinct oncogenic properties of glioblastoma stem cells. Marisetty AL; Singh SK; Nguyen TN; Coarfa C; Liu B; Majumder S Neuro Oncol; 2017 Apr; 19(4):514-523. PubMed ID: 28040710 [TBL] [Abstract][Full Text] [Related]
10. Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway. Zhou J; Yi L; Ouyang Q; Xu L; Cui H; Xu M Cell Signal; 2014 Dec; 26(12):2896-902. PubMed ID: 25200966 [TBL] [Abstract][Full Text] [Related]
11. Acid ceramidase and its inhibitors: a Doan NB; Alhajala H; Al-Gizawiy MM; Mueller WM; Rand SD; Connelly JM; Cochran EJ; Chitambar CR; Clark P; Kuo J; Schmainda KM; Mirza SP Oncotarget; 2017 Dec; 8(68):112662-112674. PubMed ID: 29348854 [TBL] [Abstract][Full Text] [Related]
12. β-elemene inhibits stemness, promotes differentiation and impairs chemoresistance to temozolomide in glioblastoma stem-like cells. Zhu TZ; Li XM; Luo LH; Song ZQ; Gao X; Li ZQ; Su JY; Liang GB Int J Oncol; 2014 Aug; 45(2):699-709. PubMed ID: 24841897 [TBL] [Abstract][Full Text] [Related]
13. Prospective study to assess the survival outcomes of planned irradiation of ipsilateral subventricular and periventricular zones in glioblastoma. Valiyaveettil D; Malik M; Akram KS; Ahmed SF; Joseph DM Ecancermedicalscience; 2020; 14():1021. PubMed ID: 32256704 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of mitochondrial UQCRB inhibits cancer stem cell-like properties in glioblastoma. Jung N; Kwon HJ; Jung HJ Int J Oncol; 2018 Jan; 52(1):241-251. PubMed ID: 29115404 [TBL] [Abstract][Full Text] [Related]
15. Coculture with astrocytes reduces the radiosensitivity of glioblastoma stem-like cells and identifies additional targets for radiosensitization. Rath BH; Wahba A; Camphausen K; Tofilon PJ Cancer Med; 2015 Nov; 4(11):1705-16. PubMed ID: 26518290 [TBL] [Abstract][Full Text] [Related]
16. A Dexamethasone-regulated Gene Signature Is Prognostic for Poor Survival in Glioblastoma Patients. Luedi MM; Singh SK; Mosley JC; Hatami M; Gumin J; Sulman EP; Lang FF; Stueber F; Zinn PO; Colen RR J Neurosurg Anesthesiol; 2017 Jan; 29(1):46-58. PubMed ID: 27653222 [TBL] [Abstract][Full Text] [Related]
17. Acetate supplementation as a means of inducing glioblastoma stem-like cell growth arrest. Long PM; Tighe SW; Driscoll HE; Fortner KA; Viapiano MS; Jaworski DM J Cell Physiol; 2015 Aug; 230(8):1929-43. PubMed ID: 25573156 [TBL] [Abstract][Full Text] [Related]
18. MiR-608 inhibits the migration and invasion of glioma stem cells by targeting macrophage migration inhibitory factor. Wang Z; Xue Y; Wang P; Zhu J; Ma J Oncol Rep; 2016 May; 35(5):2733-42. PubMed ID: 26935642 [TBL] [Abstract][Full Text] [Related]
19. Glucocorticoids promote a glioma stem cell-like phenotype and resistance to chemotherapy in human glioblastoma primary cells: Biological and prognostic significance. Kostopoulou ON; Mohammad AA; Bartek J; Winter J; Jung M; Stragliotto G; Söderberg-Nauclér C; Landázuri N Int J Cancer; 2018 Mar; 142(6):1266-1276. PubMed ID: 29067692 [TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth. Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]